GlassScriptPhysician profile
Patricia Cunnane
NPI 1184610230
$3,475.90
in general payments reported to CMS, 2019-2025
37 companies · $451 in 2025
The $451 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $429 · 2020: $158 · 2021: $248 · 2022: $433 · 2023: $1,151 · 2024: $604 · 2025: $451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,002 · Education: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,002.43 |
| Education | $204.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $528.45 | 2022-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $330.76 | 2019-2025 | Lo Loestrin Fe, Liletta, Orilissa |
| Mayne Pharma Commercial LLC | $301.92 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $281.13 | 2023-2025 | Myfembree |
| Sage Therapeutics, LLC | $185.72 | 2021-2025 | Zurzuvae |
| Allergan, INC. | $165.71 | 2019-2020 | |
| Millicent US INC | $149.33 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Exeltis, USA INC. | $129.17 | 2021-2025 | Slynd |
| Myovant Sciences INC. | $123.72 | 2021-2022 | |
| Agile Therapeutics, INC. | $120.92 | 2022-2024 | Twirla |
| Organon LLC | $96.75 | 2022-2024 | Nexplanon |
| Pfizer INC. | $88.27 | 2022-2023 | |
| Therapeuticsmd, INC. | $80.19 | 2019-2022 | |
| Myriad Women'S Health, INC. | $74.05 | 2023 | Myrisk |
| Coopersurgical, INC. | $70.33 | 2019-2025 | Ally II Ups, Mara Console |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $66.18 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $56.77 | 2019-2025 | |
| Exact Sciences Corporation | $49.69 | 2023-2025 | Cologuard Collection Kit |
| Amag Pharmaceuticals, INC. | $49.00 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $44.68 | 2019-2022 | |
| Duchesnay USA Incorporated | $44.15 | 2019 | |
| Novo Nordisk INC | $43.56 | 2023-2024 | Wegovy |
| Dysis Medical, INC. | $42.46 | 2020 | |
| Amgen INC. | $41.96 | 2019-2020 | |
| Hologic Sales and Service, LLC | $34.57 | 2023-2024 | Myosure Tissue Removal Device, Fluent Fluid Management System, Novasure |
| Aspira Women'S Health INC | $33.78 | 2021 | |
| Evofem Biosciences, INC. | $33.63 | 2022 | |
| Boston Scientific Corporation | $33.38 | 2023 | Latitude Communicator Power Supply |
| Mimedx Group, INC. | $26.95 | 2024 | |
| Avion Pharmaceuticals | $26.24 | 2019-2022 | |
| Covidien LP | $22.43 | 2019 | |
| Merck Sharp & Dohme LLC | $20.35 | 2023 | Gardasil 9 |
| Vertical Pharmaceuticals, LLC | $20.29 | 2019 | |
| Roche Diagnostics Corporation | $16.77 | 2021 | |
| Renovia INC | $16.01 | 2021 | |
| Supernus Pharmaceuticals, INC. | $15.44 | 2025 | Qelbree |
| Convatec INC. | $11.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patricia Cunnane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.